Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To establish the prevalence of acanthosis nigricans (AN) within the context of polycystic ovary syndrome (PCOS) and its associations with obesity, insulin resistance, insulinemia, and metabolic syndrome (MS).
Methods: A cross-sectional prospective study was conducted on 100 patients with PCOS diagnosed according to the Rotterdam Consensus (2003). The skin test included, in addition to the detection of the presence of AN, the presence of hirsutism (score ≥ 8) and acne. In addition to clinical and biochemical data, we investigated cardiovascular risk factors present in MS such as abdominal circumference, obesity, hypertension and HDL and triglyceride levels. Insulin resistance was determined by the HOMA-IR test.
Results: The prevalence of AN (53%) was significantly correlated with hirsutism (p = 0.02), body mass index (p < 0.01), basal insulinemia (p < 0.01), (HOMA-IR) (p < 0.01), and MS (p < 0.01). The prevalence of MS reached 36% and was significantly associated only with AN (p < 0.01). Although diabetes mellitus was absent, there was a significant association of altered HOMA-IR (p < 0.01) with MS (p < 5%) and AN (p < 0.01).
Conclusion: AN is part of the severe phenotypic profile of PCOS as an additional predictable sign of the risks of cardiovascular disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/so100-720320140005078 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combination of Si@UiO-66-NH paper-based thin film microextraction with direct solid-state spectrofluorimetry for extraction and determination of estradiol in urine.
Anal Chim Acta
November 2025
Department of Analytical Chemistry, Faculty of Chemistry, Alzahra University, Vanak, Tehran, Iran; Analytical and Bioanalytical Research Centre, Alzahra University, Vanak, Tehran, Iran. Electronic address:
Background: Determination of the estradiol hormone in urine is crucial for evaluating congenital adrenal hyperplasia, certain hormone-producing ovarian tumors, polycystic ovary syndrome, liver disease, pregnancy, and infertility. On the other hand, steroid hormones can have destructive effects on the environment, animals, and the endocrine system of humans. Consequently, accurately measuring this hormone's concentration in trace amounts is essential for environmental safety and human health.
View Article and Find Full Text PDFThe effect of hormonal contraceptives combined with vitamin D3 supplements on sexual dysfunction in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled trial.
Arch Gynecol Obstet
September 2025
Department of Midwifery, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
Background: Polycystic ovary syndrome (PCOS) is characterized by reproductive and endocrine abnormalities.
Objective: The present study aimed to assess the effect of oral contraceptive pills (OCPs) and vitamin D3 on sexual dysfunction in women with PCOS and vitamin D3 deficiency.
Materials And Methods: This randomized double-blind placebo-controlled clinical trial was conducted in Iran between January and April 2019.
Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndrome.
Clin Biochem
September 2025
The Affiliated Taian City Central Hospital of Qingdao University, 271000 Taian, China. Electronic address:
Objective: This present study aimed to measure platelet factor 4 (PF4) protein level in follicular fluid of patients with polycystic ovary syndrome (PCOS) and analyzed the correlation between follicular PF4 level with clinical characteristics.
Methods: Sixty-seven women (36 PCOS patients vs. 31 non-PCOS women) were enrolled in the study.
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities.
Cell Metab
August 2025
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong 250012, China; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Sha
Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine disorder characterized by intertwined reproductive and metabolic abnormalities. While its causal origins remain incompletely understood, accumulating evidence suggests metabolic dysfunctions-manifested by insulin resistance, obesity, hyperglycemia, and dyslipidemia-as key contributors to the pathogenesis and progression of PCOS. Emerging interventions targeting these metabolic disturbances, including caloric restriction, GLP-1-based therapies, and bariatric surgery, have shown efficacy in alleviating PCOS symptoms and potentially blocking their inheritance.
View Article and Find Full Text PDFVascular imbalance in polycystic ovary syndrome: Insights into endothelial dysfunction.
PLoS One
September 2025
Department of Biostatistics, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey.
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder associated with vascular dysfunction and increased cardiovascular risk. This study aims to investigate the dysregulation of vascular tone in PCOS, focusing on the imbalance between vasodilators (nitric oxide [NO] and apelin) and vasoconstrictors (noradrenaline and reduced prostacyclin). By examining these factors, the study seeks to elucidate their contribution to endothelial dysfunction and cardiovascular complications in PCOS patients.
View Article and Find Full Text PDF